Select a medication above to begin.
Loargys (pegzilarginase-nbln)
pegzilarginase
Black Box Warnings .
Hypersensitivity Reaction
life-threatening reactions including anaphylaxis have occurred; anaphylaxis has occurred during early tx and after extended tx duration; initiate tx in healthcare setting where appropriate medical support including cardiopulmonary resuscitation equipment available; D/C immediately and start appropriate tx if severe reaction occurs; counsel patients on signs/symptoms and to seek immediate medical attention if they occur at any time
Adult Dosing .
Dosage forms: INJ: 2 mg per 0.4 mL, 5 mg per mL
Restricted Distribution in US
- [1-844-627-4687 for more info]
- Info: only available to patients enrolled in Study IMM-PEG-005
Special Note
- [drug name clarification]
- Info: nonproprietary name = pegzilarginase-nbln
arginase 1 deficiency
- [individualize dose SC/IV qwk]
- Start: 0.1 mg/kg/dose IV qwk; Max: 0.2 mg/kg/wk; Info: consider premed with antihistamine (and corticosteroid if hypersensitivity reaction); if 2 consecutive weekly pre-dose plasma arginine levels <50 micromolar, decr. dose by 0.05 mg/kg/wk; if 2 consecutive weekly pre-dose plasma arginine levels >150 micromolar, incr. dose by 0.05 mg/kg/wk; separate doses by >4 days; may switch to SC route after 8wk of IV administration
renal dosing
- [not defined]
- renal impairment: not defined
- HD/PD: not defined
hepatic dosing
- [not defined]
Peds Dosing .
- Dosage forms: INJ: 2 mg per 0.4 mL, 5 mg per mL
Restricted Distribution in US
- [1-844-627-4687 for more info]
- Info: only available to patients enrolled in Study IMM-PEG-005
Special Note
- [drug name clarification]
- Info: nonproprietary name = pegzilarginase-nbln
arginase 1 deficiency
- [2 yo and older]
- Dose: individualize dose SC/IV qwk; Start: 0.1 mg/kg/dose IV qwk; Max: 0.2 mg/kg/wk; Info: consider premed with antihistamine (and corticosteroid if hypersensitivity reaction); if 2 consecutive weekly pre-dose plasma arginine levels <50 micromolar, decr. dose by 0.05 mg/kg/wk; if 2 consecutive weekly pre-dose plasma arginine levels >150 micromolar, incr. dose by 0.05 mg/kg/wk; separate doses by >4 days; may switch to SC route after 8wk of IV administration
renal dosing
- [not defined]
- renal impairment: not defined
- HD/PD: not defined
hepatic dosing
- [not defined]